tm
Seeing Is Believing
tm
Seeing Is Believing
MNPR is currently covered by 3 analysts with an average price target of $4.23. This is a potential upside of $3.57 (540.91%) from yesterday's end of day stock price of $0.66.
Monopar Therapeutics's activity chart (see below) currently has 2 price targets and 9 ratings on display. The stock rating distribution of MNPR is 100% BUY.
Highest price target for MNPR is $4, Lowest price target is $1, average price target is $4.23.
Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 01-Jun-2023. First documented stock forecast 24-Sep-2020.
Currently out of the existing stock ratings of MNPR, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2
10 months 24 days ago
0/4 (0%)
$1.14 (132.56%)
Buy
11
1 years 27 days ago
0/1 (0%)
$5.99 (119.56%)
What is MNPR (Monopar Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MNPR (Monopar Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MNPR (Monopar Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MNPR (Monopar Therapeutics)?
Which analyst is the currently most bullish on MNPR (Monopar Therapeutics)?
Which analyst is the currently most reserved on MNPR (Monopar Therapeutics)?
